Open AccessEffect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapy
Author(s) -
Jing Cai,
Shan Zhou,
Yuxi Luo,
Anwen Liu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000028126
Subject(s) - medicine , chemotherapy , esophageal cancer , cancer , oncology , surgery , general surgery